London CA - Search Results

1

KTN0158, a Humanized Anti-KIT Monoclonal Antibody, Demonstrates Biologic Activity against both Normal and Malignant Canine Mast Cells.

London CA, Gardner HL, Rippy S, Post G, La Perle K, Crew L, Lopresti-Morrow L, Garton AJ, McMahon G, LaVallee TM, Gedrich R. London CA, et al. Clin Cancer Res. 2017 May 15;23(10):2565-2574. doi: 10.1158/1078-0432.CCR-16-2152. Epub 2016 Nov 4. Clin Cancer Res. 2017. PMID: 27815356 Free PMC article.

2

Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial.

Vail DM, MacEwen EG, Kurzman ID, Dubielzig RR, Helfand SC, Kisseberth WC, London CA, Obradovich JE, Madewell BR, Rodriguez CO Jr, et al. Vail DM, et al. Among authors: london ca. Clin Cancer Res. 1995 Oct;1(10):1165-70. Clin Cancer Res. 1995. PMID: 9815908 Clinical Trial.

3

Inhibition of constitutively active forms of mutant kit by multitargeted indolinone tyrosine kinase inhibitors.

Liao AT, Chien MB, Shenoy N, Mendel DB, McMahon G, Cherrington JM, London CA. Liao AT, et al. Among authors: london ca. Blood. 2002 Jul 15;100(2):585-93. doi: 10.1182/blood-2001-12-0350. Blood. 2002. PMID: 12091352 Free article.

4

Activating mutations in the catalytic or juxtamembrane domain of c-kit in splenic mast cell tumors of cats.

Dank G, Chien MB, London CA. Dank G, et al. Among authors: london ca. Am J Vet Res. 2002 Aug;63(8):1129-33. doi: 10.2460/ajvr.2002.63.1129. Am J Vet Res. 2002. PMID: 12171166 Free article.

5

Prevalence and importance of internal tandem duplications in exons 11 and 12 of c-kit in mast cell tumors of dogs.

Downing S, Chien MB, Kass PH, Moore PE, London CA. Downing S, et al. Among authors: london ca. Am J Vet Res. 2002 Dec;63(12):1718-23. doi: 10.2460/ajvr.2002.63.1718. Am J Vet Res. 2002. PMID: 12492288 Free article.

6

Phase I dose-escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies.

London CA, Hannah AL, Zadovoskaya R, Chien MB, Kollias-Baker C, Rosenberg M, Downing S, Post G, Boucher J, Shenoy N, Mendel DB, McMahon G, Cherrington JM. London CA, et al. Clin Cancer Res. 2003 Jul;9(7):2755-68. Clin Cancer Res. 2003. PMID: 12855656 Clinical Trial.

7

Proof of target for SU11654: inhibition of KIT phosphorylation in canine mast cell tumors.

Pryer NK, Lee LB, Zadovaskaya R, Yu X, Sukbuntherng J, Cherrington JM, London CA. Pryer NK, et al. Among authors: london ca. Clin Cancer Res. 2003 Nov 15;9(15):5729-34. Clin Cancer Res. 2003. PMID: 14654558

8

Detection of c-kit mutations in canine mast cell tumors using fluorescent polyacrylamide gel electrophoresis.

Jones CL, Grahn RA, Chien MB, Lyons LA, London CA. Jones CL, et al. Among authors: london ca. J Vet Diagn Invest. 2004 Mar;16(2):95-100. doi: 10.1177/104063870401600201. J Vet Diagn Invest. 2004. PMID: 15053358

9

Use of kit internal tandem duplications to establish mast cell tumor clonality in 2 dogs.

Zavodovskaya R, Chien MB, London CA. Zavodovskaya R, et al. Among authors: london ca. J Vet Intern Med. 2004 Nov-Dec;18(6):915-7. doi: 10.1892/0891-6640(2004)18<915:uokitd>2.0.co;2. J Vet Intern Med. 2004. PMID: 15638281 Free article.

10

Evaluation of dysregulation of the receptor tyrosine kinases Kit, Flt3, and Met in histiocytic sarcomas of dogs.

Zavodovskaya R, Liao AT, Jones CL, Yip B, Chien MB, Moore PF, London CA. Zavodovskaya R, et al. Among authors: london ca. Am J Vet Res. 2006 Apr;67(4):633-41. doi: 10.2460/ajvr.67.4.633. Am J Vet Res. 2006. PMID: 16579756 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

141 results

Search Page

Filters